Processa Pharmaceuticals Inc
Company Profile
Business description
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its "regulatory science" approach in the development of Next Generation Chemotherapy ("NGC") oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small molecule oncology drugs. The NGC products are new chemical entities, but the company work by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are - NGC-Capecitabine (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).
Contact
7380 Coca Cola Drive
Suite 106
Hanover MD 21076
USAT: +1 443 776-3133
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
13
Stocks News & Analysis
stocks
Going into earnings, Is Apple stock a buy, a sell, or fairly valued?
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
---|---|---|---|
All Ordinaries | 8,153.40 | 59.10 | 0.73% |
CAC 40 | 7,517.68 | 90.66 | 1.22% |
DAX 40 | 18,417.55 | 118.83 | 0.65% |
Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
FTSE 100 | 8,285.71 | 99.36 | 1.21% |
HKSE | 17,021.31 | 16.34 | 0.10% |
NASDAQ | 17,357.88 | 176.16 | 1.03% |
Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
S&P 500 | 5,459.10 | 59.88 | 1.11% |
S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
---|---|---|---|
Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |